FOXNews.com: FDA extends review for Pfizer arthritis drug by three months

FOXNews.com FOX News Network - We Report. You Decide.

FDA extends review for Pfizer arthritis drug by three months Aug 22nd 2012, 11:17 The U.S. Food and Drug Administration extended by three months its review of Pfizer Inc's experimental rheumatoid arthritis treatment tofacitinib, one of the most promising new drugs in the company's pipeline

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions